Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06282536
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-02-21
Brief Title:
Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC A Single Arm Exploratory Trial
Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Organization:
Shanghai Pulmonary Hospital Shanghai China
Organization Data
Organization:
Shanghai Pulmonary Hospital Shanghai China
Class:
OTHER
Study ID:
LungMate-018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Lead Sponsor Class:
OTHER
Responsible Party:
Peng Zhang
Responsible Party Title:
Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Pulmonary Hospital Shanghai China
Old Name:
None
Old Organization:
None